Welcome to UK420

Register now to gain access to all of our features. Once registered and logged in, you will be able to contribute to this site by submitting your own content or replying to existing content. You'll be able to customize your profile, receive reputation points as a reward for submitting content, while also communicating with other members via your own private inbox, plus much more!

This message will be removed once you have signed in.

Search the Community: Showing results for tags 'israel'.



More search options

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


Forums

  • Welcome to UK420
    • New Members
  • Cultivation
    • Strain Base
    • Breeders Help Desks
    • Compost and Pots
    • Hydroponics
    • Outdoor Growing
    • Propagation, Cloning and Mother Plants
    • Auto Flowering
    • Growroom Design
    • Problem Solver
    • Harvesting and Processing
    • Grow Diaries
    • Cream Of The Crop
  • Cannabis Culture
    • News, Views and Politics
    • Medicinal Cannabis
    • Smokers Lounge
    • Uk420 Competitions
  • Sponsor Support
    • Intense Nutrients
    • Vapefiend - The Vaporizer Specialists
    • DIY LED UK
    • Gro-zone Hydro

Calendars

  • Community Calendar

Found 14 results

  1. Hi Government throws its weight behind medical cannabis sector Ministry report on the ecosystem’s key players and government incentives is aimed at attracting foreign investment With the issuance of a wide-ranging ministry report on the medical cannabis industry, Israel is for the first time making clear its intention to back the burgeoning sector, according to a ministry official. The white paper on Israel’s Medical Cannabis Innovation, published earlier this month, maps out the industry’s ecosystem — the key players, leading startups, breakthrough research at academic institutions, government regulations, and opportunities that await investors should they decide to take the plunge. “This is a statement by the State of Israel that it is promoting the sector of cannabis for medical use,” just as it has previously promoted the cybersecurity and auto-technology industries, said Ziva Eger, the chief executive at Invest in Israel, the Ministry of Economy and Industry’s arm for promoting foreign investment in Israel. This is “the first time,” she said, that the state is addressing the cannabis sector as a field it is eager to develop. “We identify the potential and have created a base for all of our work in Israel so we can market it abroad.” There are a growing number of foreign investors who are interested in Israel’s cannabis ecosystem, she said. The global medical cannabis industry is expected to grow from $13.4 billion in 2018 to $44 billion by 2024, according to the IMARC Group. This surge is driven by an increasing acceptance that the plant-based drug can be used to alleviate a wide range of afflictions. Gradual legalization in countries around the world is helping boost the industry. Since 2013, some 35 nations have permitted the use of medical cannabis, along with 33 states in the US. Canada has the most advanced regulatory system in place and is home to nine out of the 10 largest cannabis companies worldwide. Canada is also the world’s leading cannabis exporter. “The world is marching in the direction of medical cannabis for wellness, and that cannot be ignored,” said Aviad Tamir, the head of life sciences and healthcare at Invest in Israel. This is a field in which Israel is identified as having “technological superiority,” he said. “After Canada, Israel is the most advanced country regarding regulation and licensing,” Eger said. The roots of Israel’s flourishing medical cannabis industry go back to the 1960s research of Prof. Raphael Mechoulam, a pioneer in the field who identified two of the active ingredients of the plant, tetrahydrocannabinol, or THC, and cannabidiol (CBD). “Nowadays, Israel has various entities conducting research in the medical cannabis field, from top universities to private companies and even governmental institutes,” according to the report. “Teams are looking into the effects of cannabis in a wide range of areas, including cancer, PTSD, autism, epilepsy, Crohn’s disease and schizophrenia,” with a number of clinical trials underway. In January 2019, the government approved the export of medical grade cannabis, expected to yield as much as $1 billion in revenues a year, though the final bureaucratic nod is still needed. It will hopefully come in the first quarter of 2020, once a new government is in place, said Eger. In addition, pharma firms in Israel as well as health providers are all open to medical cannabis, and are involved in the research and regulatory processes. “The idea is to take a deep look at where the advantages are and create partnerships,” said Eger. The report lists some of the leading Israeli companies, startups and investors operating in the sector, as well as service providers, regulations and government incentives. The firms listed include Roots – Sustainable Agricultural Technologies, which enables temperature control to provide the cannabis plant with optimal conditions at every stage of cultivation; DryGair Energies Ltd., which does the same with humidity control; Seedo, which has created a fridge-like home lab to grow cannabis; and Syqe, which has developed a medical marijuana inhaler. Still, the Israeli medical cannabis field has not been without its controversies. Medical pot firm Breath of Life in October shelved its much-touted initial public offering of shares on the Toronto Stock Exchange, awaiting better market conditions. Tikkun Olam, the first company to get a license from the Health Ministry to grow medical cannabis in Israel, lost its permit, reportedly based on a police recommendation. In addition, a reform of the medical cannabis supply system in Israel has left patients facing an acute shortage, with some turning to the black market and addictive opioids to deal with their condition. “These are growing pains,” said Eger. “It will take one or two years for the market to stabilize. This is just the beginning.” But, she added “there is a window of opportunity” of one or two years in which Israel can capitalize on its relative advantage in the field. “What doesn’t happen in this time, will be lost.” https://www.timesofisrael.com/government-throws-its-weight-behind-medical-cannabis-sector/ Bongme
  2. Horizon BBC2, 9pm, Wednesday 28th August - Tonight! website has four mini clips: https://www.bbc.co.uk/programmes/p07l1j08 Just watched, same bull about psychosis and paranoia, but hey ho, here we go… Trail - Cannabis: Miracle Medicine or Dangerous Drug? Dr Javid Abdelmoneim explores the latest research behind whether medicinal cannabis will help or harm patients - and what it does to the body and brain. The Godfather of Cannabis Dr Javid Abdelmoneim meets Professor Mechoulam, otherwise known as the 'Godfather of Cannabis'. Javid takes part in a cannabis trial Dr Javid Abdelmoneim takes part in a trial at King's College London, testing the effect of cannabis on his body and brain. Can cannabis treat pain in the elderly? Dr Javid Abdelmoneim meets Professor Victor Novack, a scientist studying the elderly population of medical cannabis users in Israel. "So British..." M
  3. Clinical Trial: Metered Dosing of Herbal Cannabis Effective in Hospitalized Patients Haifa, Israel: Hospitalized patients administered cannabis via a metered dose inhaler report symptom relief and no severe adverse effects, according to clinical data published in the journal Palliative & Supportive Care. Israeli investigators assessed the safety, feasibility, and efficacy of metered dose cannabis inhalation in a group of hospitalized patients. The device allowed for patients to self-administer precise quantities of cannabis in a vaporized (non-combustion) form. All patients reported reduced pain symptoms following cannabis inhalation. Several subjects also reported relief from nausea and spasticity. No severe adverse effects were reported by any of the study's participants. Three-quarters of the participants reported the inhaler to be "easy to use." Authors concluded, "[T]he current study results have demonstrated the feasibility of administrating cannabis using the Syqe Inhaler, allowing for the first time, to administer small, safe, accurate, precise, and reliable dosages of cannabinoids" in a hospital setting. https://norml.org/news/2019/07/03/clinical-trial-metered-dosing-of-herbal-cannabis-effective-in-hospitalized-patients
  4. https://www.jpost.com/Israel-News/Jack-Pot-Armed-robbers-steal-medical-cannabis-from-farm-in-Galilee-585395 Masked and armed robbers raided a legal medical cannabis farm in the Sea of Galilee area, taking an unknown amount of cannabis. Police are investigating the incident. T he first major medical cannabis robbery was reported in Northern Israel this week, according to the Hebrew business publication Globes.Masked and armed robbers raided a legal medical cannabis farm in the Sea of Galilee area, taking an unknown amount of cannabis. Police are investigating the incident. The event comes as cannabis takes a front-and-center role in the upcoming April 9 election, with parties debating whether to make not only medical cannabis but recreational marijuana legal.Israel recently made substantial reforms in the field of medical cannabis, legalizing its export, and providing opportunity for more farms to receive permits to grow pot.The global medical cannabis market was valued at $8.3 billion in 2017 and is projected to rise to $28b. by 2024, according to a report by Energias Market Research. For Israeli companies to tap into the market, they will need both approval by the Health Ministry and the police.
  5. https://www.timesofisrael.com/former-israel-police-chief-takes-job-pushing-medical-cannabis-worldwide/ An Israeli medical marijuana producer announced Wednesday that it had appointed as chairman of its board former Israel Police commissioner Yohanan Danino, who had called for rethinking policy on recreational use of cannabis while he was still serving as the country’s top cop. Together Pharma, which specializes in growing and distributing medical cannabis, said in a statement that Danino will lead “international business development activities, including the promotion of collaboration agreements with global players.” “The medical cannabis market is one of the fastest growing markets in the world which provides significant opportunities for Together Pharma, certainly in view of the export approval from Israel,” Danino said in the statement. “The medical community, leading policymakers, and caregivers today fully admit that the medicinal benefits of the plant are unequivocal. “Cannabis plant products provide a cure for patients daily, worldwide and in a wide variety of indications, whether they are patients suffering from cancer, epilepsy, pain, autism, depression, post-trauma and more,” he added. Nissim Bracha, CEO of Together Pharma, said that under Danino’s chairmanship of the board of directors the company will aim at “collaborating with leading players in the global medical cannabis industry.” Then Israeli chief of police Yohanan Danino, February 11, 2015. (Yonatan Sindel/FLASH90) Danino served as Israel Police commissioner from 2011 to 2015. He was also previously chairman of the Migdal Insurance company, one of the largest in the country. While still filling the role of police chief, Danino called on the government to reassess its policies on the recreational use of marijuana. Noting the increasing calls for cannabis to be made legal, Danino said in 2015, “I think it’s time for the police, along with the state, to reevaluate its traditional position.” In April 2018, Together said it had reached a binding agreement to sell five tons of cannabis oil to a Canadian company that it didn’t name. The deal could potentially yield revenue of hundreds of millions of shekels, the Israeli firm said at the time. Israel is known as a pioneer in cannabis research, and there are government estimates that the economy could reap $285 million to $1.14 billion a year from the industry. An estimated 50 Israeli medical marijuana companies work in cultivating plants or producing delivery devices for the drug in Israel, according to Reuters. Last month cabinet ministers approved the export of medical cannabis, paving the way for Israeli marijuana growers to begin international sales. With the approval Israel joined the Netherlands and Canada as nations allowing the legal export of medical cannabis. Ehud Barak, the former prime minister, is also chairman of a medical cannabis firm, InterCure, which announced the appointment in September.
  6. Hello everybody, i am not sure whether this is the right place to post this. Moderators, if you think it isn't, please move it where you think it's more appropriate. So, i'll try to be as brief as i can and get straight to the point. Am a seed collector. Have a friend in Israel, who doesn't smoke so can't help me as his friends also don't smoke. I, sooner or later, will go and visit him and would like to take the opportunity of doing both things. Visiting my friend and looking for ISRAELI LANDRACES SEEDS. Never been to Israel and don't even know whether a landrace from israel exists. Does any one know if such a strain exists? and if so where it is grown or which place in israel it originates from? Do you know of nay particular name (for the landrace in question) and village/area i could go to / look into? If you have any pic of such a native plant don't hesitate to attach it here. If you know of a farmer who produces plants and seeds, i'd be grateful for any info. I can also go directly to the farmer/producer/merchant and buy the seeds. Thanks to anyone who can help me with my quest Dan
  7. Hi New Medical Marijuana Regulations in Israel Allow Public Cannabis Consumption Medical marijuana patients in Israel are now allowed to use cannabis oils and vaporizers in public places. Israel has been a leader in medical marijuana research for years, and now, thanks to a new set of directives released by the country’s Health Ministry, the state is setting a new standard of accommodation by allowing medical patients to legally consume cannabis in public. According to Haaretz, the new directives went into effect immediately and now permit the use of cannabis oils and vaporizers in public spaces. Smoking marijuana in public will remain illegal, but a rule change made in March means that even lighting up in downtown Tel Aviv will only result in a citation and a fine. Before the most recent directives, medical marijuana patients had their medicine directly tied to their place of residence, and even possessing pot outside of the address on a patient’s medical cannabis license was a punishable offense. It also prevented patients from taking cannabis on vacation and made changing residences difficult. Now, Israel’s cannabis regulators are happy to do away with the antiquated system. “We felt that a lot of bureaucracy was created over nothing,” Yuval Landschaft, the head of the Israeli Health Ministry’s cannabis unit told Haaretz. The new regulations still ban vaping weed and using cannabis oils at schools, airports and a few other select locations, but Israel’s 30,000 medical marijuana patients will now be able to add cannabis oil to their food at restaurants or vape flowers while walking down the street. While America’s version of legalization has generally continued to treat cannabis like a narcotic substance, Israel is taking an approach that puts patients first, and the country’s officials aren’t shy about it. “[The new rules] are part of the medicalization of medical cannabis as much as possible.” Landschaft said. “We see great value in helping make things easier for patients who need it.” https://merryjane.com/news/israel-allows-public-cannabis-consumption Bongme
  8. Hi Can a robot help your hydroponic garden grow? By Gwen Ackerman Bloomberg 3/18/2017 Karin Kloosterman, co-founder of Flux IoT, prepares her tiny robot "Eddy," which can detect nutrient deficiency in plants, in a pop up greenhouse during its development to help produce food from water in the Jaffa district of Tel Aviv, Israel, on Feb. 26, 2017. Bloomberg photo by Rina Castelnuovo. On a rooftop in the Jewish-Arab Tel Aviv neighborhood of Jaffa, a former military technologist and an ex-journalist sit in a transparent bio-dome where their robot is busy learning how to grow food. Flux IoT's Eddy, a robot measuring less than a foot tall and resembling a life buoy, is built with military-grade sensors and armed with image-processing technology. Its inventors intend it to become the industry standard for commercial and amateur indoor farmers who want to grow pesticide-free, water-efficient crops via hydroponics -- a method of growing plants without soil. Eddy sits in the growing reservoir, and users can stay updated on their crops' progress via a mobile app, where information gleaned from fellow farmers can help them know when to change the lighting or add nutrients. Amichai Yifrach, co-founder and chief technology officer of Flux. IoT, left, and Karin Kloosterman, co-founder of Flux IoT, assemble their robot during developmental testing in a pop up greenhouse in the Jaffa district of Tel Aviv, Israel, on Feb. 26, 2017. Bloomberg photo by Rina Castelnuovo. - Currently closing a $2 million seed funding to start manufacturing, Flux is planning another financing round of as much as $8 million later this year, its size dependent on how many robots sell on crowdfunding platform Indiegogo Inc., said Chief Executive Officer Blake Burris. It's also growing its U.S. team, primarily based in Colorado, while research and development will remain in Israel. The Israeli team is led by co-founder and Chief Technology Officer Amichai Yifrach, who previously built nano sniffers to detect explosives and image processing tools to protect U.S. troops at checkpoints in Afghanistan and Iraq. "In the army you build perimeter security using imaging processes and webcams that can see things the human eye can't," said Flux VP of marketing and co-founder Karin Kloosterman, a former journalist. "With that technology Eddy can look at a plant and detect nutrient deficiency and tell you what it is. Right now you have to be a trained agronomist to know." Zirra.com, an Israeli startup that uses artificial intelligence and machine learning to analyze the private tech market, says Flux's offering "poses significant disruption in their relevant space," but that the price of the robot could be a "showstopper." Burris says they plan to sell Eddy for $179, and expect to sell anywhere between 10,000 to 25,000 robots this year. Rival SmartBee Controllers, which provides water content sensors, sells starter systems starting at $2,500. A water content sensor alone costs between $350 and $400. Hydroponic farming is growing in importance as government agencies such as the U.S. Department of Agriculture reflect on the potential impact of industrial or conventional farming, including soil productivity decline, pollution and depletion of natural resources such as water. A robot known as "Eddy" which is being developed to support hydroponic farming sits among plants during testing in a pop up greenhouse in the Jaffa district of Tel Aviv, Israel, on Feb. 26, 2017. - Bloomberg photo by Rina Castelnuovo According to global market research firm IBISWorld, the U.S. hydroponic industry alone will reach $856.8 million by 2021, from $821 million in 2016 and the number of businesses will jump from 2,347 to more than 3,000. Flux sees home gardeners as a target market, and in the U.S. 42 million households grow food at home, according to The National Gardening Association. Scotts Miracle-Grow Co., the world's largest seller of lawn and garden products, bought an Arizona-based company in October to boost its hydroponics offering. New Zealand-based Bluelab, a global supplier of testing and control equipment for hydroponics, gives basic readings that are linked to a computer and is also working on a mobile app. One of the big markets for hydroponic equipment are cannabis growers. Flux will assemble the first few thousand robots in Israel, and if demand expands as expected, manufacturing will move to China shortly thereafter. The intersect in hydroponics is also spreading between worlds. Elon Musk has plans for a Martian colony, NASA is trying hydroponics out in space, and the European Space Agency is cooperating with the Space Farm Collective led by a Netherlands Border Labs team on ways to grow food on planets other than Earth. Thieme Hennis, head of the Space Farm Collective, is testing out Eddy to see how it might help a citizen science project called Watch Me Grow, aimed at finding plants that will grow best in space, and improve ways even the public can grow their own food on Earth. "Eddy has to prove itself on a larger scale, but something like this is necessary and offers an interface for nonprofessional and professional growers alike to understand and 'talk' with plants," said Hennis. http://www.dailyherald.com/article/20170318/business/170318991/ Bongme
  9. Medical Cannabis Patient Sues Health Ministry for Negligence A medical marijuana patient whose license to grow his own cannabis was revoked in 2013, has filed a lawsuit against Israel’s health ministry for providing him with plants tainted by dangerous pesticides which are illegal for human consumption. “Patient R” is one of only a dozen Israelis who have been issued permits to grow his own plants, and is the only patient involved in the lawsuit. “He is suing the health ministry for providing him with dangerous substances and for not having clear rules for using pesticides in medical cannabis in Israel,” Oren Lebovich, chairman of the Green Leaf Organization and editor-in-chief of the Israeli Cannabis Magazine, told The Media Line. Israel is known as one of the largest producers of medical marijuana in the world; at least 23,000 Israelis have prescriptions to purchase the drugs. Many of them suffer from cancer, chronic pain and a number of other ailments. Patient R claims to have become sick after obtaining his cannabis plants from Teva-Adir, one of the eight suppliers in Israel, even finding mold in some of the flowers. Upon this discovery in 2013, he approached the ministry of health, but was ignored. He then consulted criminal lawyer Yaniv Peretz, who sent Patient R’s cannabis sample from Teva-Adir along with samples from two other suppliers, Tikun Olam and Seach, to be tested at the Israeli Chemical Testing Laboratory by Israeli cannabis researcher, Dr. Noam Chehanovsky. Chehanovsky allegedly found contamination from nine pesticides in the Tikun Olam sample, according to Peretz. Fungicides, insecticides, and plant growth regulators in potentially dangerous quantities were reportedly discovered in the sample. Tikun Olam denies any use of pesticides. “According to our chief agronomist, who has a Ph.D. in agriculture, and other experts, we cannot reply to the findings of the report that was sent to us because they did not send the batch numbers or where they took the samples from and how the tests that they did were done,” Ma’ayan Weisberg, head of international relations at Tikun Olam told The Media Line. “These pesticides are not allowed to be used on food and here we are talking about medicine and a medicine that has to be heated up for consumption,” Lebovich said. “Heating up these pesticides is really bad because the chemicals go through the lungs and not through any filters, like the liver, which filters the dangerous stuff out when you eat contaminated foods.” In addition to the contamination issue, all but three Tikun Olam samples had much lower values – as much as 20 percent — than advertised of active compounds, like THC, the psychoactive compound that can relieve pain and increase appetite, according to Chehanovsky’s report. “THC levels are the most important thing when dealing with cancer patients, who use cannabis as a treatment,” Lebovich said. For example, Eran-Almog, one strain in question, is advertised as having a THC range of 24%-28%, when, in reality, after testing, it only had 3.2% THC, Lebovich said. According to Peretz, after sending Dr. Chehanovsky’s findings to the health ministry, he received a response suggesting using a different supplier. “With these bad results, I would have expected the health ministry to have been more determined to look into this finding,” Peretz said. “The Ministry of Health asked for more information from me instead of checking the suppliers.” Peretz said he then consulted the opinion of Tuvia Yaacoby, a former Chief Herbologist for the Plant Protection and Inspection Services Department at the Ministry of Agriculture and Rural Development. “It is highly concerning the amount of pesticides found in the cannabis,” Yaacoby told The Media Line. “This was shocking especially after finding out that there was a government announcement on the 26th of June articulating that medical cannabis be grown according to good practices. The government didn’t mention the use of pesticides.” Yaacoby, whose job was to check and regulate pesticides in Israel, believes that using pesticides is very dangerous, especially for sick patients. “I am talking about inhaling carbon monoxide and nitrogen and other poisonous gases. I am looking at cannabis like Tylenol because it is a medicine and it should be treated like using a medicine and it should be clean and pure, without any residues like pesticides,” Yaacoby said. http://www.themedialine.org/top-stories/medical-cannabis-patient-sues-health-ministry-negligence/
  10. Hi Joint relief: Marijuana helps mend broken bones Tel Aviv University scientists find cannabis speeds healing of fractures, may be used to treat bone-related diseases By Judah Ari Gross July 16, 2015 Break a bone? Your doctor may soon provide you with an unexpected prescription – marijuana. Researchers at Tel Aviv University have discovered that a component of marijuana “significantly helps heal bone fractures,” university officials announced Thursday. The study, published in the Journal of Bone and Mineral Research, found that the non-psychotropic cannabidiol, or CBD, considerably sped up the healing process of rats’ broken leg bones. Those benefits were also present, even when the molecule was separated from THC, the major psychoactive component of cannabis. Dr. Yankel Gabet of Tel Aviv’s Bone Research Laboratory and the late Prof. Itai Bab of Hebrew University’s Bone Laboratory discovered the connection between our bodies’ cannabinoid receptors and the stimulation of bone growth, which may be used for future research into the use of marijuana to treat not only broken bones but also osteoporosis and other skeletal diseases. “The clinical potential of cannabinoid-related compounds is simply undeniable at this point,” Gabet said. “While there is still a lot of work to be done to develop appropriate therapies, it is clear that it is possible to detach a clinical therapy objective from the psychoactivity of cannabis. CBD, the principal agent in our study, is primarily anti-inflammatory and has no psychoactivity.” To test which molecule is responsible for the enhanced bone growth, the researchers divided the test subjects and injected one group with just CBD and the other with both CBD and THC. “We found CBD alone to be sufficiently effective in enhancing fracture healing,” Gabet said. “Other studies have also shown CBD to be a safe agent, which leads us to believe we should continue this line of study in clinical trials to assess its usefulness in improving human fracture healing.” Not only does marijuana encourage the healing process, it also prevents future injury, researchers found. “After being treated with CBD, the healed bone will be harder to break in the future,” Gabet explained. Medicinal marijuana is currently used to reduce some of the adverse effects of chemotherapy in cancer patients, improve the appetites of AIDS patients and generally as a treatment for chronic pain, including post-traumatic stress disorder. Recently, however, researchers have been investigating the use of medicinal cannabis as a treatment for Parkinson’s Disease, multiple sclerosis and some forms of cancer. http://www.timesofisrael.com/joint-relief-marijuana-helps-mend-broken-bones/ Bongme
  11. Bill to cancel criminal penalties for marijuana possession faces opposition from ministers of health, public security A vote on a bill to decriminalize possession of small amounts of marijuana has been delayed a week due to opposition from Public Security Minister Gilad Erdan and Health Minister Yaakov Litzman. The legislation was scheduled to come up for a vote in the Ministerial Committee for Legislation on Sunday, but opposition from two key ministers responsible for enforcing it has led one of its authors, Likud’s MK Sharren Haskel, to delay the vote “in order to reach an agreement with my faction colleague” Erdan. According to the Hebrew-language online magazine Cannabis, which supports the measure, the bill would decriminalize possession of up to 15 grams of cannabis for anyone over the age of 21. Those caught in their home with a “personal” amount of cannabis would pay a fine of NIS 300 ($78) and those caught in public would be fined NIS 1,500 ($390). The new policy would not change the punishment for those caught growing the drug in their homes or for users under the age of 21, the report said. Supporters are said to have launched an advocacy campaign, flooding Erdan’s office over the weekend with calls to support the bill. In March, similar legislation was rejected by the Ministerial Committee for Legislation that would have allowed up to five grams of cannabis for personal use. Legalization of cannabis enjoys widespread support across the political spectrum. Haskel’s bill is co-authored by Arab Joint List MK Dov Henin. On Wednesday, Justice Minister Ayelet Shaked (Jewish Home) said the Justice Ministry is exploring the possibility of decriminalizing the use of soft drugs generally, including cannabis. Shaked told Army Radio that under the potential new guidelines her ministry was considering issuing, the use of soft drug would still be illegal, but would not carry criminal penalties. Those caught using them would pay a fine only. When the interviewer asked Shaked whether this could be the first step in legalizing soft drugs, the minister stressed that “we are talking about decriminalization, not legalization.” The rationale behind the potential new policy, Shaked said, is that the use of soft drugs is too widespread to be considered criminal, but by issuing fines it remained an act formally forbidden by the government. Shaked said she began looking into changing the policy towards soft drugs soon after entering office last year, and that extensive work had already been done on the matter. Among Western countries, Israel already has one of the highest per capita rates of legal cannabis use, with over 21,000 people medically licensed to use the drug. http://www.timesofisrael.com/cabinet-vote-on-decriminalizing-cannabis-delayed-a-week/
  12. Hi Perspective: Israel leading the world in cannabis research In Israel, a country not as strict on marijuana use as the US, technicians and researchers are studying the medical benefits of marijuana. They began cannabis research 50 years ago. Researchers in Israel have created a strain of cannabis that doesn’t give the effects of “being high,” to the user, but still has potency in its Cannabinoid (CBD) properties. The new strain, named “Rafael,” cannot be exported due to legal issues, but its development and research is catching the eye of people in search for alternatives all over the world. Eventually we may see cannabis used in pill form produced by pharmaceuticals. The properties of marijuana are already being used to treat those who suffer from chronic seizures in America, but the “taboo” of using cannabis, classified as a Schedule I drug, is preventing others in criminalized states from getting the help they need. Some of the sufferer’s stories can be found in TIME article titled “Pot Kids.” Parents struggle to control the seizures of their epileptic children. One 3-year-old girl was having up to 200 seizures a day. Her body couldn’t find remedies in over-the-counter prescriptions. Since this issue is so prevalent in American families all over, one would think it’s time to help save these children and help them find peace with the medical uses of cannabis. Compared to Israel and its research, America is falling behind in taking care of its children all due to an outdated classification of marijuana. Hopefully after the Israeli investor’s conference being held this Thursday, more Americans will tune into the research and facts that have to do with medical properties in cannabis, especially since this conference is featuring a Colorado doctor. For those who suffer from pain that cannot be relieved by traditional pharmaceuticals, maybe this is the godsend the world has been waiting for. Until that happens, ill people are still forced to deal with the inconvenient side effects that come from popping various pills. If you are someone who suffers from an illness like Crohn’s disease, basal cell carcinoma, Parkinson’s, PTSD, multiple sclerosis or others, you may benefit from CBD and its effects. Michigan is a medical marijuana state that allows controlled purchases of the marijuana plant from caregivers in the area. Michiganders are lucky, but not everyone else in the country of the free has this privilege. Israel’s research may be able to help the world understand the healing benefits of cannabis, and we may see the drug federally reclassified in our lifetime. http://www.oaklandpostonline.com/blogs/article_0a634406-ab61-11e4-89ef-1b7d8bfe7514.html One Comment and this is it.... I'm a Scientist with a strong interest in Cancer research. The evidence of the value of Marijuana as a life saving medicine is now so strong that the need to remove Marijuana from Schedule 1 has become a moral imperative. This weekend over 3,000 Americans died, in pain, of Cancer. Today, tomorrow and every day after that, 1,500 more Americans will die, after suffering horribly, from it. Every single minute another American dies of Cancer. Every American Cancer patient deserves the right to have safe, legal, and economical access to Medical Marijuana. Every single one. Americans who need Medical Marijuana shouldn't be used as "Political Footballs" Please call the Whitehouse comment line at (202) 456-1111 and ask that the President take immediate action to remove Marijuana from Schedule 1 so American Physicians in all 50 states can prescribe it. Go to petitions.whitehouse.gov -- there are two petitions you can sign electronically there, one to take Marijuana off of Schedule 1, the other to legalize it completely. Bongme
  13. Hi ‘Designer strains’ of cannabis could cure more ills An Israeli crop developer aims at maximizing marijuana’s medical benefits while reducing its high By David Shamah December 7, 2014 Two Israeli companies that have been working to improve medical marijuana have submitted applications for the approval of two new cannabis strains genetically bred to manage medical conditions more effectively than those current available. Israel is one of about a dozen countries and US states that allow the use of marijuana for medical purposes, and one of the few where growing cannabis for use in medical treatment is legal. Under rules adopted last year, patients who want to use marijuana to relieve chronic pain or treat other conditions (such as psychosis) apply to one of 31 authorized doctors for a prescription, which is dispensed at authorized pharmacies. There are eight licensed growers in Israel, one of which is a company called Seach Ltd. Seach has teamed up with an Israeli software developer called BreedIT, which has devised a technique to help breeders modify crops to emphasize specific traits. The new joint development project, formed in August, is called KanaboSeed. The BreedIT system is based in part by research conducted by Professors Haim Rabinowitch and Nachum Kedar of Hebrew University, most famous for their work in developing popular strains of cherry tomatoes and perfecting long-life tomatoes that contain a ripening inhibitor gene to guarantee a longer shelf life. The new technology, according to BreedIT CEO Dr. Oded Sagee, is essential to the development of the medical marijuana industry – which Sagee believes is set for a major worldwide expansion. “We decided to develop an organized breeding program to assist breeders to develop new breeds of cannabis,” Sagee said in an interview earlier this year. Currently, he said, the available strains are not optimized for medical use. “We believe that with our knowledge and background we will be able to develop new breeds that will be more effective,” he added. Sagee, along with the other researchers working in the nascent medical marijuana business, is hoping to develop strains of cannabis that have improved CBD-to-THC ratios. THC, or tetrahydrocannabinol, is the chemical responsible for most of marijuana’s psychological effects, and is the component of cannabis that most interests casual users of cannabis; the more THC, the better the high. Those who use marijuana to relieve chronic pain also seek strains with higher levels of THC than CBD; those strains are more effective at masking pain. CBD, or cannabidiol, has been shown in many studies to have important medical benefits, such as in the treatment of schizophrenia, depression, rheumatoid arthritis, colitis, liver inflammation, heart disease and diabetes. A good example of engineered cannabis is Avidekel, a strain developed by Israeli cannabis breeder Tikun Olam, which has a very high level of CBD and a very low level of THC. Sagee said that KanaboSeed is working with researchers to develop “designer strains” of cannabis that will contain components to treat specific medical issues, without the psychotropic effects of THC. The applications submitted by KanaboSeed, said Sagee, “are just the first of what we anticipate will be a line of new potential cannabis varieties that KanaboSeed is developing to address specific medical uses. We intend to capitalize on the commercialization of new varieties, as allowed by the laws and regulations, in Israel and other countries where regulation permits the use of medical cannabis.” The Agriculture Ministry and the Rural Development Plant Breeders’ Rights Council will review the applications. Hearings will be held about granting the license (no date has been set), with the public invited to give their opinions. The company will grow the new strains (on land belonging to Seach), which will be evaluated by the agencies, and once approved, the company will be granted a registration (the equivalent of a patent) for the strains. Shay Avraham Sarid, KanaboSeed’s manager of Research and Development, said that the applications were “an important milestone for KanaboSeed. The BreedIT team contributes significant value to our development efforts, most notably the ability to streamline the breeding process. In addition to saving time, we are also developing new varieties more cost-effectively. Together we are building a product pipeline that will provide numerous opportunities for revenue growth going forward.” http://www.timesofisrael.com/designer-strains-of-cannabis-could-cure-more-ills/ Bongme
  14. Hi Israel develops revolutionary medical marijuana inhaler November 28, 2014 (ISRAEL21c)—A first-in-class pocket-sized metered-dose cannabis inhaler helps patients and doctors control, monitor and fine-tune dosages. As medical marijuana debates heat up across the globe, a government-backed Israeli startup has developed the first device of its kind to administer cannabis as a pharmaceutical. Unlike the current methods—smoking joints, imbibing oil, rubbing in a salve or eating laced brownies—this medical device enables the patient to inhale metered doses of vaporized cannabis granules. The Syqe Inhaler is the brainchild of Perry Davidson, an entrepreneur who was instrumental in launching the Israeli Health Ministry’s Medical Cannabis Program in 2007, for the treatment of chronic nausea, pain and other conditions. Some 20,000 Israelis today take doctor-prescribed cannabis, and Israel is at the forefront of research and development in this field. Pilot testing of the inhaler will start in hospitals around the country by the end of 2014. A home version of the device is expected to go on the market sometime in 2015. Davidson formed Syqe Medical —a homophone of the word “psyche”—to tackle some of the problems surrounding the use of this controlled substance as a mainstream drug. He sought a scientific way to separate marijuana’s stigma as an illicit recreational drug from its proven health benefits. For complete article go to Israel21c.org http://www.heritagefl.com/story/2014/11/28/features/israel-develops-revolutionary-medical-marijuana-inhaler/3644.html Bongme